Nothing Special   »   [go: up one dir, main page]

GB648619A - Process of producing sponges of gelatine and the like proteins - Google Patents

Process of producing sponges of gelatine and the like proteins

Info

Publication number
GB648619A
GB648619A GB8149/48A GB814948A GB648619A GB 648619 A GB648619 A GB 648619A GB 8149/48 A GB8149/48 A GB 8149/48A GB 814948 A GB814948 A GB 814948A GB 648619 A GB648619 A GB 648619A
Authority
GB
United Kingdom
Prior art keywords
proteins
drying
blood
sponges
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8149/48A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Ferrosan ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan ApS filed Critical Ferrosan ApS
Publication of GB648619A publication Critical patent/GB648619A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/30Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by mixing gases into liquid compositions or plastisols, e.g. frothing with air
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00Characterised by the use of proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

Sponges, particularly for use for absorbing blood and excretions, are formed by dissolving gelatine or like proteins having no anti-genetic action, such as human plasma or fibrinogen or de-antigenized animal proteins, in water containing a hardening-agent such as formaldehyde, introducing air or like gas and drying the resulting foam, a surface-active agent, e.g. sulphonated lauryl alcohol or p-amino-benzene-sulphonamido-thiazole having been added at any time prior to drying. A blood-coagulant and an antibacterial substance may be incorporated.ALSO:Sponges, particularly for use for absorbing blood and excretions, are formed by dissolving gelatine or like proteins having no antigenetic action, such as human plasma or fibrinogen or de-antigenized animal proteins, in water containing a hardening-agent such as formaldehyde, introducing air or like gas and drying the resulting foam, a surface-active agent, e.g. sulphonated lauryl alcohol or p-amino-benzene-sulphonamido-thiazole having been added at any time prior to drying. A blood-coagulant and an antibacterial substance may be incorporated.ALSO:Sponges, particularly for use for absorbing blood and excretions, are formed by dissolving gelatine or like proteins having no antigenetic action such as human plasma or fibrinogen or de-antigenized animal proteins in water containing a hardening-agent such as formaldehyde, introducing air or like gas and drying the resulting foam, a surface-active agent, e.g. sulphonated lauryl alcohol or p-amino-benzene-sulphonamido-thiazole having been added at any time prior to drying. A blood-coagulant and an antibacterial substance may be incorporated.
GB8149/48A 1947-03-19 1948-03-18 Process of producing sponges of gelatine and the like proteins Expired GB648619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK648619X 1947-03-19

Publications (1)

Publication Number Publication Date
GB648619A true GB648619A (en) 1951-01-10

Family

ID=8152006

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8149/48A Expired GB648619A (en) 1947-03-19 1948-03-18 Process of producing sponges of gelatine and the like proteins

Country Status (1)

Country Link
GB (1) GB648619A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923031B2 (en) 2004-01-30 2011-04-12 Ferrosan Medical Devices A/S Haemostatic sprays and compositions
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US7955288B2 (en) 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
US8021684B2 (en) 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US8283320B2 (en) 2001-12-21 2012-10-09 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
US7955288B2 (en) 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
US7923031B2 (en) 2004-01-30 2011-04-12 Ferrosan Medical Devices A/S Haemostatic sprays and compositions
US8021684B2 (en) 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US10799611B2 (en) 2012-06-12 2020-10-13 Ferrosan Medical Devices A/S Dry haemostatic composition
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9999703B2 (en) 2012-06-12 2018-06-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10595837B2 (en) 2013-06-21 2020-03-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US11103616B2 (en) 2013-12-11 2021-08-31 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Similar Documents

Publication Publication Date Title
GB648619A (en) Process of producing sponges of gelatine and the like proteins
NL140275B (en) METHOD OF INFLAMMATING CELLULAR PLASTIC MASSES.
CH295840A (en) Process for the production of an agent for the simultaneous cleaning and disinfection of the body
FR940097A (en) Sterilization process
SU77385A1 (en) The method of obtaining artificial porous skin
DK79085C (en) Process for the preparation of resorbable sponges for the absorption of blood and other excreta.
GB806950A (en) Production of pharmaceutical preparations
NL151128B (en) PROCESS FOR THE PREPARATION OF LOW FOAMING DETERGENTS AND THE MOLDED DETERGENTS THEREFORE OBTAINED.
GB634502A (en) Therapeutic sponge
NL147735B (en) PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION AND A PROCESS FOR THE PREPARATION OF THE ACTIVE COMPOUNDS TO BE USED THEREIN.
AT183871B (en) Process for the preparation of aqueous solutions containing lactoflavin
NL148783B (en) PROCESS FOR THE PREPARATION OF PREPARATIONS WITH HERBICIDE ACTIVITY AND PROCESS FOR THE PREPARATION OF HERBICIDE ACTIVE TRIAZINE DERIVATIVES.
CH284940A (en) Process for the preparation of 4-amino-6- (2'-amino-6'-methyl-pyrimidyl-4'-amino) -quinaldine-1,1'-dimethiodide.
FR954313A (en) Dehydration of aqueous alcohol mixtures
GB585675A (en) Improvements in or relating to detergent solutions
AT170861B (en) Process for the preparation of the biologically active 3,3'-bis-4-hydroxycoumarinylacetone
FR1078204A (en) Method of controlling the foaming of aqueous soap solutions and resulting solution
AT180565B (en) Process for the preparation of D-threo-1-p-nitrophenyl-2-dichloroacetamino-1,3-propanediol
GR13490B (en) MIXTURE FOR CLEANING PRESERVATION AND DISINFECTION OF CLOTHES, CARPETS AND SKIN.
GB644264A (en) Improvements in or relating to apparatus for improving the biological properties of air in rooms
AT171406B (en) Process for the preparation of optically active heterocyclic derivatives of 4,4-diphenylheptanone- (5)
ES177820A1 (en) IMPROVEMENTS IN THE MANUFACTURE OF HAIR TISSUES
ES15978U (en) Therapeutic sponge (Machine-translation by Google Translate, not legally binding)
ES173865A1 (en) IMPROVEMENTS INTRODUCED IN THE MANUFACTURE OF KNIVES
FR1004485A (en) Toys in the form of snowmen and animals